Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,924Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Intuniv

PharmaCompass

01

Brand Name : Intuniv

Guanfacine

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Brand Name : Intuniv

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Guanfacine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 79

2018 Revenue in Millions : 43

Growth (%) : 85

blank

02

Brand Name : Intuniv

Guanfacine

arrow
Interphex
Not Confirmed

03

Brand Name : Intuniv

Guanfacine

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Brand Name : Intuniv

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Guanfacine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 176

2019 Revenue in Millions : 117

Growth (%) : 50

blank

04

Brand Name : Intuniv

Guanfacine

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Brand Name : Intuniv

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Guanfacine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 125

2019 Revenue in Millions : 81

Growth (%) : 55

blank

05

Brand Name : Intuniv

Guanfacine

arrow
Interphex
Not Confirmed

06

Brand Name : Intuniv

Guanfacine

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Brand Name : Intuniv

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Guanfacine

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 0

2020 Revenue in Millions : 168

Growth (%) : -100

blank

07

Brand Name : Intuniv

Guanfacine

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Brand Name : Intuniv

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Guanfacine

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 153

2020 Revenue in Millions : 0

Growth (%) : 100

blank

08

Brand Name : Intuniv

Guanfacine

arrow
Interphex
Not Confirmed

09

Brand Name : Intuniv

Guanfacine

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Brand Name : Intuniv

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Guanfacine

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 177

2021 Revenue in Millions : 153

Growth (%) : 16

blank

10

Brand Name : Intuniv

Guanfacine

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Brand Name : Intuniv

arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Guanfacine

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 171

2022 Revenue in Millions : 177

Growth (%) : 9

blank